As of 2024-12-15, the EV/EBITDA ratio of Emerald Health Therapeutics Inc (EMH.CN) is 0.46. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EMH.CN's latest enterprise value is -7.79 mil CAD. EMH.CN's TTM EBITDA according to its financial statements is -16.96 mil CAD. Dividing these 2 quantities gives us the above EMH.CN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.1x - 17.2x | 13.6x |
| Forward P/E multiples | 22.0x - 35.5x | 28.8x |
| Fair Price | (1.68) - (1.29) | (1.61) |
| Upside | -4891.2% - -3792.2% | -4709.5% |
| Date | EV/EBITDA |